Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Virginia Borges

Concepts (592)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
147
2026
2447
12.470
 Why?
Pregnancy Complications, Neoplastic
16
2026
63
3.330
 Why?
Postpartum Period
20
2026
361
2.850
 Why?
Cancer Survivors
19
2025
326
2.320
 Why?
Receptors, Estrogen
22
2026
457
2.150
 Why?
Antineoplastic Combined Chemotherapy Protocols
21
2025
1953
1.900
 Why?
Antineoplastic Agents, Hormonal
14
2025
194
1.860
 Why?
Carcinoma, Ductal, Breast
10
2023
88
1.700
 Why?
Mastectomy
17
2024
162
1.620
 Why?
Protein Kinase Inhibitors
7
2025
968
1.420
 Why?
Lactation
9
2021
192
1.240
 Why?
Brain Neoplasms
11
2025
1318
1.220
 Why?
Female
166
2026
77976
1.170
 Why?
Receptors, Progesterone
9
2026
356
1.150
 Why?
Carcinoma, Intraductal, Noninfiltrating
7
2023
61
1.110
 Why?
Neoplasm Metastasis
13
2025
688
1.060
 Why?
Breast
10
2021
157
1.020
 Why?
Adult
100
2026
40262
0.980
 Why?
Triple Negative Breast Neoplasms
7
2025
215
0.950
 Why?
Oxazoles
8
2025
48
0.950
 Why?
Antineoplastic Agents
12
2023
2192
0.920
 Why?
Pregnancy
36
2026
7180
0.900
 Why?
Trastuzumab
13
2023
118
0.890
 Why?
Humans
175
2026
144261
0.870
 Why?
Pyridines
9
2025
605
0.860
 Why?
Quinazolines
8
2025
266
0.840
 Why?
Mammary Glands, Human
7
2020
67
0.840
 Why?
Supreme Court Decisions
1
2022
12
0.750
 Why?
Mammary Glands, Animal
9
2021
128
0.700
 Why?
Carcinoma
3
2021
227
0.680
 Why?
BRCA2 Protein
5
2024
67
0.680
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.660
 Why?
Semaphorins
4
2025
37
0.660
 Why?
Fertility Preservation
7
2025
53
0.650
 Why?
Maternal Age
1
2020
126
0.610
 Why?
Breast Feeding
6
2025
448
0.610
 Why?
Middle Aged
59
2026
35762
0.610
 Why?
Drug Resistance, Neoplasm
3
2022
881
0.600
 Why?
Antigens, CD
6
2025
555
0.590
 Why?
Neoplasm Staging
19
2026
1461
0.590
 Why?
Prospective Studies
33
2025
7970
0.580
 Why?
Neoadjuvant Therapy
6
2021
462
0.580
 Why?
Estradiol
5
2019
533
0.570
 Why?
Prognosis
16
2026
4278
0.560
 Why?
Extracellular Vesicles
1
2020
170
0.540
 Why?
Young Adult
38
2026
13990
0.540
 Why?
Carcinoma in Situ
3
2022
44
0.540
 Why?
Parity
7
2022
109
0.530
 Why?
Biomarkers, Tumor
12
2026
1313
0.530
 Why?
Lymphatic Metastasis
10
2021
333
0.510
 Why?
Neoplasm Recurrence, Local
13
2023
1137
0.510
 Why?
Neoplasms, Second Primary
3
2024
100
0.500
 Why?
Quality of Life
12
2025
3166
0.490
 Why?
Chemotherapy, Adjuvant
14
2025
419
0.480
 Why?
Cyclooxygenase 2
5
2020
165
0.470
 Why?
Mutation
11
2025
4085
0.430
 Why?
Capecitabine
5
2023
57
0.420
 Why?
Melanoma
4
2018
760
0.420
 Why?
Aromatase Inhibitors
6
2019
75
0.420
 Why?
Carcinoma, Lobular
2
2012
56
0.410
 Why?
Skin Neoplasms
4
2013
847
0.410
 Why?
Liver Neoplasms
4
2016
780
0.410
 Why?
Mastectomy, Segmental
6
2022
108
0.410
 Why?
Combined Modality Therapy
10
2023
1264
0.400
 Why?
Puerperal Disorders
2
2014
37
0.390
 Why?
BRCA1 Protein
4
2024
81
0.380
 Why?
Disease-Free Survival
8
2026
768
0.370
 Why?
Stromal Cells
3
2013
124
0.360
 Why?
Tumor Suppressor Protein p53
2
2021
529
0.350
 Why?
Genes, BRCA2
3
2026
33
0.350
 Why?
Genes, BRCA1
3
2026
45
0.350
 Why?
Anxiety
7
2022
1104
0.340
 Why?
Neoplasms
7
2026
2870
0.340
 Why?
Sexual Partners
3
2022
187
0.330
 Why?
Nevus, Pigmented
1
2011
35
0.330
 Why?
Epithelial Cells
6
2018
1125
0.330
 Why?
Neoplasm Invasiveness
6
2020
508
0.320
 Why?
Fertility
5
2025
168
0.310
 Why?
Social Support
4
2025
649
0.310
 Why?
Tamoxifen
7
2021
217
0.310
 Why?
Aged
30
2026
25850
0.300
 Why?
Estrogens
4
2015
380
0.300
 Why?
Cyclophosphamide
5
2020
266
0.300
 Why?
Radiosurgery
3
2021
400
0.300
 Why?
Adjuvants, Immunologic
2
2022
245
0.300
 Why?
Antibodies, Monoclonal, Humanized
7
2025
985
0.290
 Why?
Gene Expression Profiling
8
2020
1782
0.290
 Why?
Risk Factors
17
2024
10699
0.290
 Why?
Thrombophilia
1
2009
88
0.290
 Why?
T-Lymphocytes
6
2018
1982
0.290
 Why?
Cohort Studies
12
2025
5935
0.280
 Why?
Patient Acceptance of Health Care
2
2025
878
0.280
 Why?
GPI-Linked Proteins
4
2025
80
0.280
 Why?
Incidence
7
2024
2870
0.280
 Why?
Cell Line, Tumor
10
2025
3539
0.270
 Why?
Quinolines
3
2025
190
0.270
 Why?
Mice
21
2025
18329
0.270
 Why?
Animals
31
2025
38030
0.270
 Why?
Heterozygote
2
2026
315
0.270
 Why?
Breast Neoplasms, Male
2
2018
29
0.270
 Why?
Doxorubicin
5
2020
397
0.270
 Why?
Gene Expression Regulation, Neoplastic
4
2021
1455
0.270
 Why?
Employment
2
2019
185
0.260
 Why?
Kaplan-Meier Estimate
4
2020
964
0.260
 Why?
Premenopause
5
2025
123
0.250
 Why?
Decision Making
4
2022
974
0.250
 Why?
Lymphocytes, Tumor-Infiltrating
2
2026
154
0.250
 Why?
Maytansine
2
2018
18
0.250
 Why?
Myeloid-Derived Suppressor Cells
2
2018
72
0.250
 Why?
Estrogen Receptor alpha
3
2025
161
0.240
 Why?
Adaptation, Psychological
2
2022
706
0.240
 Why?
Time Factors
7
2020
7155
0.240
 Why?
Disease Management
3
2021
643
0.230
 Why?
Follow-Up Studies
6
2025
5389
0.230
 Why?
Estrogen Receptor Antagonists
1
2025
4
0.230
 Why?
Reproductive History
2
2015
12
0.230
 Why?
Hematopoietic Stem Cell Transplantation
1
2011
674
0.230
 Why?
Ovarian Reserve
1
2025
17
0.230
 Why?
Germ-Line Mutation
1
2026
172
0.230
 Why?
CD8-Positive T-Lymphocytes
5
2023
917
0.220
 Why?
Primary Ovarian Insufficiency
1
2025
40
0.220
 Why?
Mammography
3
2025
165
0.220
 Why?
Dimethyl Sulfoxide
1
2005
41
0.220
 Why?
Macrophages
4
2018
1510
0.220
 Why?
Cell Plasticity
1
2025
37
0.220
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2022
108
0.220
 Why?
Proportional Hazards Models
2
2022
1322
0.220
 Why?
Genetic Predisposition to Disease
6
2024
2359
0.210
 Why?
Transforming Growth Factor beta1
1
2025
177
0.210
 Why?
Spectrometry, Mass, Electrospray Ionization
1
2005
178
0.210
 Why?
Adolescent
20
2024
22281
0.210
 Why?
Bupropion
1
2004
46
0.210
 Why?
Reproductive Techniques, Assisted
1
2024
43
0.210
 Why?
Disease Progression
10
2020
2840
0.210
 Why?
Lymph Nodes
3
2019
502
0.200
 Why?
Treatment Outcome
10
2026
11643
0.200
 Why?
Drug Administration Schedule
3
2018
778
0.200
 Why?
Tumor Microenvironment
7
2026
732
0.200
 Why?
Diarrhea
3
2019
192
0.200
 Why?
Immunotherapy
3
2025
652
0.200
 Why?
Cell Proliferation
5
2021
2494
0.190
 Why?
Disease Models, Animal
5
2020
4556
0.190
 Why?
Pharmaceutical Preparations
1
2005
169
0.190
 Why?
Liver
3
2020
1884
0.190
 Why?
Hypertension, Pregnancy-Induced
1
2023
67
0.190
 Why?
Multiple Sclerosis
1
2008
484
0.190
 Why?
Age Factors
9
2021
3313
0.190
 Why?
Aurora Kinase A
2
2019
62
0.180
 Why?
Women's Health
1
2024
308
0.180
 Why?
Chromatography, Liquid
1
2004
454
0.180
 Why?
Retrospective Studies
11
2026
17009
0.180
 Why?
Pilonidal Sinus
1
2001
4
0.180
 Why?
Genomic Instability
1
2022
66
0.180
 Why?
Condylomata Acuminata
1
2001
7
0.180
 Why?
Antineoplastic Agents, Immunological
3
2019
199
0.180
 Why?
Drug Monitoring
2
2019
389
0.180
 Why?
Proteomics
2
2020
1191
0.180
 Why?
Hematopoiesis
1
2022
194
0.170
 Why?
Nausea
2
2018
111
0.170
 Why?
Aged, 80 and over
7
2025
8243
0.170
 Why?
Genetic Testing
3
2026
478
0.170
 Why?
Piperazines
1
2023
380
0.170
 Why?
Ki-67 Antigen
2
2019
117
0.170
 Why?
Mass Spectrometry
1
2004
744
0.160
 Why?
Dyspareunia
1
2020
8
0.160
 Why?
Mice, Inbred BALB C
6
2019
1253
0.160
 Why?
Body Image
3
2020
97
0.160
 Why?
Cancer Care Facilities
1
2020
48
0.160
 Why?
Ibuprofen
2
2018
84
0.160
 Why?
Pregnancy-Associated Plasma Protein-A
1
2020
14
0.160
 Why?
Biopsy
4
2018
1075
0.160
 Why?
Risk
3
2013
909
0.160
 Why?
Neoplasm Grading
5
2021
307
0.160
 Why?
Resistance Training
1
2022
180
0.150
 Why?
Carcinoma, Non-Small-Cell Lung
2
2021
1180
0.150
 Why?
Mice, Inbred NOD
1
2021
610
0.150
 Why?
p21-Activated Kinases
1
2019
14
0.150
 Why?
Benzodiazepines
1
2021
165
0.150
 Why?
Bone Neoplasms
2
2016
253
0.150
 Why?
Sexual Health
1
2020
66
0.150
 Why?
Fatigue
2
2018
361
0.150
 Why?
Cell Adhesion
1
2020
454
0.150
 Why?
Immunohistochemistry
8
2019
1715
0.150
 Why?
Parkinson Disease
2
2015
600
0.150
 Why?
Receptor, trkB
1
2019
36
0.140
 Why?
Sexual Dysfunctions, Psychological
1
2019
30
0.140
 Why?
Carcinoma, Ductal
2
2011
10
0.140
 Why?
Lymphangiogenesis
2
2018
27
0.140
 Why?
Response Evaluation Criteria in Solid Tumors
1
2018
21
0.140
 Why?
Germ Cells
3
2024
66
0.140
 Why?
Cell Communication
1
2020
324
0.140
 Why?
Pyrazoles
3
2018
509
0.140
 Why?
Nuclear Receptor Subfamily 1, Group F, Member 3
1
2018
14
0.140
 Why?
Stress, Psychological
2
2025
1147
0.140
 Why?
Tryptophan Oxygenase
1
2018
33
0.140
 Why?
Ipilimumab
1
2018
39
0.140
 Why?
Neoplasm Proteins
2
2020
442
0.140
 Why?
Sexual Dysfunction, Physiological
1
2019
74
0.140
 Why?
Progesterone
2
2025
255
0.140
 Why?
Cisplatin
1
2020
334
0.130
 Why?
Brain-Derived Neurotrophic Factor
1
2019
148
0.130
 Why?
Parenting
1
2022
317
0.130
 Why?
Vitamin D
1
2021
399
0.130
 Why?
Area Under Curve
1
2018
329
0.130
 Why?
Cross-Sectional Studies
7
2025
5813
0.130
 Why?
T-Lymphocytes, Regulatory
2
2018
388
0.130
 Why?
United States
8
2025
15876
0.130
 Why?
Tretinoin
1
2018
124
0.130
 Why?
Receptors, Antigen, T-Cell
2
2023
668
0.130
 Why?
Immunity, Mucosal
1
2018
98
0.130
 Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.130
 Why?
Patient Care Management
1
2017
56
0.130
 Why?
Tryptophan
1
2018
180
0.130
 Why?
Granulocytes
1
2017
80
0.130
 Why?
Socioeconomic Factors
5
2021
1312
0.120
 Why?
Case-Control Studies
3
2020
3592
0.120
 Why?
Global Health
1
2020
394
0.120
 Why?
Drug Delivery Systems
2
2010
379
0.120
 Why?
Carcinoma, Squamous Cell
1
2001
641
0.120
 Why?
Protein-Tyrosine Kinases
1
2019
433
0.120
 Why?
Metaplasia
1
2016
57
0.120
 Why?
Pancreatic Cyst
1
2017
50
0.120
 Why?
Cell Transformation, Neoplastic
3
2015
339
0.120
 Why?
Radiotherapy, Image-Guided
1
2016
39
0.120
 Why?
Surveys and Questionnaires
8
2024
6021
0.120
 Why?
Prostatic Neoplasms
2
2021
974
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
99
0.120
 Why?
Dyskinesia, Drug-Induced
1
1995
14
0.120
 Why?
Cellular Microenvironment
1
2016
94
0.120
 Why?
Levodopa
1
1995
41
0.120
 Why?
Epithelium
2
2015
314
0.120
 Why?
Antiparkinson Agents
1
1995
41
0.120
 Why?
Cytophagocytosis
1
2015
4
0.110
 Why?
Depression
3
2020
1533
0.110
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
338
0.110
 Why?
Prophylactic Surgical Procedures
1
2015
7
0.110
 Why?
Adherens Junctions
1
2015
24
0.110
 Why?
Transforming Growth Factor beta3
1
2015
15
0.110
 Why?
Lung Neoplasms
2
2021
2637
0.110
 Why?
Paracrine Communication
1
2015
67
0.110
 Why?
Menarche
1
2015
52
0.110
 Why?
Phosphoproteins
2
2015
343
0.110
 Why?
Rats
6
2021
5592
0.110
 Why?
Chronic Pain
1
2019
290
0.110
 Why?
Lymphocyte Activation
3
2017
1126
0.110
 Why?
Risk Reduction Behavior
1
2016
225
0.110
 Why?
Lymph Node Excision
2
2021
173
0.110
 Why?
Spleen
1
2017
508
0.110
 Why?
Microfilament Proteins
1
2015
135
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Pyrimidines
1
2018
532
0.110
 Why?
Survival Analysis
4
2021
1382
0.110
 Why?
Gastrointestinal Microbiome
1
2022
771
0.110
 Why?
Survivors
3
2023
516
0.110
 Why?
Aging
1
2025
1964
0.110
 Why?
Extracellular Matrix
2
2016
553
0.110
 Why?
Amenorrhea
1
2014
31
0.110
 Why?
Mammary Neoplasms, Animal
1
2014
34
0.100
 Why?
Odds Ratio
4
2020
1072
0.100
 Why?
Administration, Oral
3
2025
847
0.100
 Why?
Calcium-Binding Proteins
1
2015
219
0.100
 Why?
Carbon Cycle
1
2014
14
0.100
 Why?
Brain Edema
1
2014
62
0.100
 Why?
Multivariate Analysis
2
2019
1533
0.100
 Why?
Droughts
1
2014
32
0.100
 Why?
Monocytes
1
2017
538
0.100
 Why?
Pregnancy Outcome
3
2023
476
0.100
 Why?
Disability Evaluation
1
2015
308
0.100
 Why?
Collagen
2
2021
455
0.100
 Why?
Spouses
1
2015
108
0.100
 Why?
Tremor
1
1994
98
0.100
 Why?
Male
20
2022
72035
0.100
 Why?
Astrocytes
1
2015
222
0.100
 Why?
Neoplastic Cells, Circulating
2
2016
81
0.100
 Why?
Signal Transduction
4
2020
5221
0.100
 Why?
Atmosphere
1
2014
87
0.100
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2012
981
0.100
 Why?
Antigens, Differentiation, Myelomonocytic
3
2019
65
0.100
 Why?
Infertility, Female
1
2014
112
0.100
 Why?
Nitriles
1
2014
205
0.100
 Why?
Trans-Activators
1
2015
405
0.100
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
28
0.090
 Why?
Lymphatic Vessels
3
2019
63
0.090
 Why?
Triazoles
1
2014
184
0.090
 Why?
Postural Balance
1
2015
240
0.090
 Why?
Myeloid Cells
1
2013
148
0.090
 Why?
Genome-Wide Association Study
1
2019
1406
0.090
 Why?
Apoptosis
3
2019
2430
0.090
 Why?
Cardiovascular Diseases
1
2024
2134
0.090
 Why?
Drug Design
1
2013
173
0.090
 Why?
Live Birth
2
2023
68
0.090
 Why?
Analgesics, Opioid
1
2021
1131
0.090
 Why?
Logistic Models
5
2016
2104
0.090
 Why?
Genes, Bacterial
1
2012
166
0.090
 Why?
Fibrillar Collagens
1
2011
14
0.090
 Why?
Interpersonal Relations
1
2015
399
0.090
 Why?
Wound Healing
1
2014
351
0.090
 Why?
Mice, Inbred C57BL
6
2019
5988
0.090
 Why?
Double-Blind Method
3
2021
2025
0.090
 Why?
Patient Participation
1
2015
429
0.090
 Why?
Real-Time Polymerase Chain Reaction
1
2012
341
0.090
 Why?
Transcriptome
2
2021
1044
0.080
 Why?
Antigen Presentation
2
2018
205
0.080
 Why?
Membrane Proteins
2
2015
1165
0.080
 Why?
B7-H1 Antigen
2
2026
241
0.080
 Why?
Biopsy, Needle
1
2011
183
0.080
 Why?
Streptococcus agalactiae
1
2012
108
0.080
 Why?
Xenograft Model Antitumor Assays
3
2020
928
0.080
 Why?
Estrogen Antagonists
1
2010
48
0.080
 Why?
Adenocarcinoma
2
2015
927
0.080
 Why?
Sexual Behavior
1
2014
484
0.080
 Why?
Cell Fusion
2
2006
49
0.080
 Why?
Pregnancy Trimester, Second
1
2009
82
0.070
 Why?
Clinical Trials as Topic
3
2017
1050
0.070
 Why?
Radiotherapy, Adjuvant
2
2021
222
0.070
 Why?
Sentinel Lymph Node Biopsy
3
2021
118
0.070
 Why?
Mucin-1
1
2009
22
0.070
 Why?
Reference Standards
2
2012
177
0.070
 Why?
Cell Movement
3
2019
965
0.070
 Why?
In Situ Hybridization, Fluorescence
3
2019
322
0.070
 Why?
Pregnancy Trimester, First
1
2009
135
0.070
 Why?
Interferon beta-1a
1
2008
14
0.070
 Why?
Glatiramer Acetate
1
2008
18
0.070
 Why?
Macrophage Activation
1
2010
193
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
186
0.070
 Why?
Clinical Trials, Phase I as Topic
2
2020
52
0.070
 Why?
Rats, Sprague-Dawley
4
2016
2525
0.070
 Why?
Dose-Response Relationship, Drug
3
2018
2026
0.070
 Why?
Metalloproteases
1
2008
42
0.070
 Why?
Interferon-beta
1
2008
92
0.070
 Why?
Sensitivity and Specificity
3
2013
1983
0.070
 Why?
Extracellular Matrix Proteins
1
2009
157
0.070
 Why?
Gonadal Steroid Hormones
1
2009
144
0.070
 Why?
Age of Onset
2
2021
536
0.070
 Why?
Phenotype
3
2026
3157
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2009
381
0.060
 Why?
Cell Cycle
2
2021
596
0.060
 Why?
Disease Susceptibility
1
2009
346
0.060
 Why?
Genomics
2
2023
833
0.060
 Why?
Maximum Tolerated Dose
2
2018
212
0.060
 Why?
ErbB Receptors
3
2017
627
0.060
 Why?
Gene Knockdown Techniques
2
2020
336
0.060
 Why?
Sternum
1
2006
26
0.060
 Why?
Mice, Nude
3
2015
682
0.060
 Why?
HIV Infections
1
2001
3079
0.060
 Why?
Antibodies, Monoclonal
3
2009
1519
0.060
 Why?
Cell Survival
2
2020
1098
0.060
 Why?
Membrane Glycoproteins
2
2019
496
0.060
 Why?
Cells, Cultured
3
2019
4146
0.060
 Why?
Mammaplasty
2
2021
104
0.060
 Why?
Ovariectomy
2
2019
162
0.060
 Why?
Polymerase Chain Reaction
2
2016
1054
0.060
 Why?
Postmenopause
2
2005
391
0.060
 Why?
Axilla
2
2021
51
0.060
 Why?
Keratins
1
2026
172
0.060
 Why?
Child
6
2022
22537
0.060
 Why?
Forkhead Transcription Factors
2
2018
202
0.060
 Why?
Prolactin
1
2025
89
0.060
 Why?
Models, Biological
2
2012
1820
0.060
 Why?
Fear
2
2021
366
0.060
 Why?
Anti-Mullerian Hormone
1
2025
57
0.060
 Why?
Mice, Knockout
2
2025
3119
0.060
 Why?
Thyrotropin
1
2025
118
0.060
 Why?
Infant, Newborn
2
2023
6424
0.050
 Why?
PTEN Phosphohydrolase
1
2026
164
0.050
 Why?
Dendritic Cells
2
2005
499
0.050
 Why?
Enzyme Inhibitors
1
2008
824
0.050
 Why?
Analysis of Variance
3
2014
1304
0.050
 Why?
Solubility
1
2005
242
0.050
 Why?
Congresses as Topic
1
2026
221
0.050
 Why?
Ovulation Induction
1
2024
56
0.050
 Why?
Neoplastic Processes
1
2023
5
0.050
 Why?
Follicle Stimulating Hormone
1
2025
249
0.050
 Why?
Cancer Vaccines
1
2005
160
0.050
 Why?
Weaning
2
2016
46
0.050
 Why?
Epithelial-Mesenchymal Transition
1
2025
219
0.050
 Why?
North America
1
2024
310
0.050
 Why?
Cryopreservation
1
2024
110
0.050
 Why?
Celecoxib
2
2014
41
0.050
 Why?
Peptide YY
1
2022
24
0.050
 Why?
Ghrelin
1
2022
38
0.050
 Why?
Sensation
1
2022
55
0.050
 Why?
Withholding Treatment
1
2023
80
0.050
 Why?
DNA End-Joining Repair
1
2022
22
0.050
 Why?
Peptides
1
2008
995
0.050
 Why?
Appetite
1
2022
69
0.050
 Why?
Mucins
1
2022
76
0.050
 Why?
Cost of Illness
1
2024
319
0.050
 Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2023
331
0.040
 Why?
Chromosome Aberrations
1
2022
162
0.040
 Why?
Colorado
3
2020
4562
0.040
 Why?
Multiple Myeloma
1
2005
291
0.040
 Why?
Psychiatric Status Rating Scales
2
2015
537
0.040
 Why?
Chemoradiotherapy, Adjuvant
1
2021
44
0.040
 Why?
Evidence-Based Medicine
1
2025
729
0.040
 Why?
Genes, p53
1
2021
67
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2021
117
0.040
 Why?
Hypertrophy
1
2021
127
0.040
 Why?
Placebos
1
2021
192
0.040
 Why?
In Situ Hybridization
1
2001
319
0.040
 Why?
Reproducibility of Results
2
2012
3403
0.040
 Why?
Protective Agents
1
2021
42
0.040
 Why?
Referral and Consultation
1
2007
847
0.040
 Why?
Societies, Medical
1
2025
886
0.040
 Why?
Immunity
1
2021
139
0.040
 Why?
Neoplasm, Residual
1
2021
139
0.040
 Why?
Hormones
1
2021
134
0.040
 Why?
DNA Replication
1
2022
250
0.040
 Why?
Early Detection of Cancer
1
2026
462
0.040
 Why?
Hospitals, University
1
2021
176
0.040
 Why?
Pregnancy Rate
1
2020
69
0.040
 Why?
CD4-Positive T-Lymphocytes
2
2019
1128
0.040
 Why?
Arm
1
2021
109
0.040
 Why?
Cross-Over Studies
1
2022
600
0.040
 Why?
Flow Cytometry
3
2013
1172
0.040
 Why?
DNA Repair
1
2022
255
0.040
 Why?
Morbidity
1
2021
323
0.040
 Why?
Consolidation Chemotherapy
1
2019
10
0.040
 Why?
Confidence Intervals
1
2020
333
0.040
 Why?
Multicenter Studies as Topic
1
2021
402
0.040
 Why?
Patient Reported Outcome Measures
1
2024
487
0.040
 Why?
Age Distribution
1
2020
397
0.040
 Why?
Kidney Neoplasms
1
2004
412
0.040
 Why?
SEER Program
1
2021
224
0.040
 Why?
Energy Intake
1
2022
499
0.040
 Why?
DNA, Viral
1
2001
358
0.040
 Why?
Base Sequence
2
2016
2187
0.040
 Why?
Vaginal Diseases
1
2019
18
0.040
 Why?
Unemployment
1
2019
41
0.040
 Why?
Fibronectins
1
2020
136
0.040
 Why?
Severity of Illness Index
2
2019
2917
0.040
 Why?
Leuprolide
1
2019
21
0.040
 Why?
Terminology as Topic
1
2021
255
0.040
 Why?
Mammary Neoplasms, Experimental
1
2019
70
0.040
 Why?
Sulfonamides
2
2014
580
0.040
 Why?
Interleukin-10
2
2014
309
0.040
 Why?
Crosses, Genetic
1
2018
124
0.040
 Why?
Hot Flashes
1
2019
88
0.030
 Why?
Weight Gain
1
2022
556
0.030
 Why?
Maintenance Chemotherapy
1
2018
42
0.030
 Why?
Factor Analysis, Statistical
1
2019
292
0.030
 Why?
Integrins
1
2018
89
0.030
 Why?
Body Weight
1
2022
976
0.030
 Why?
Proto-Oncogene Proteins c-myc
1
2019
167
0.030
 Why?
Antimetabolites, Antineoplastic
1
2018
105
0.030
 Why?
Kynurenine
1
2018
113
0.030
 Why?
Contraceptives, Oral
1
2017
37
0.030
 Why?
RNA, Small Interfering
1
2020
634
0.030
 Why?
Behavior
1
2018
91
0.030
 Why?
Patient Satisfaction
1
2021
704
0.030
 Why?
Dietary Supplements
1
2021
575
0.030
 Why?
Educational Status
1
2019
464
0.030
 Why?
Tumor Escape
1
2017
49
0.030
 Why?
Weight Loss
1
2022
832
0.030
 Why?
Drug Therapy, Combination
1
2019
1044
0.030
 Why?
National Cancer Institute (U.S.)
1
2016
52
0.030
 Why?
Emulsions
1
2016
57
0.030
 Why?
Cell Count
1
2017
320
0.030
 Why?
Alleles
1
2019
878
0.030
 Why?
Stress Disorders, Post-Traumatic
1
2024
884
0.030
 Why?
Risk Assessment
2
2020
3637
0.030
 Why?
Immune Tolerance
1
2018
379
0.030
 Why?
Population Surveillance
1
2019
483
0.030
 Why?
Radiotherapy Dosage
1
2016
289
0.030
 Why?
Immunophenotyping
1
2017
322
0.030
 Why?
Antigens, Differentiation
1
2015
77
0.030
 Why?
Radiotherapy Planning, Computer-Assisted
1
2016
149
0.030
 Why?
Body Mass Index
2
2015
2420
0.030
 Why?
Directive Counseling
1
2015
44
0.030
 Why?
Molecular Targeted Therapy
1
2018
431
0.030
 Why?
Hybrid Cells
2
2005
49
0.030
 Why?
Medication Adherence
1
2019
512
0.030
 Why?
Reproduction
1
2016
207
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1705
0.030
 Why?
Biomarkers
2
2021
4254
0.030
 Why?
Medicare
1
2021
881
0.030
 Why?
Amyloid Precursor Protein Secretases
1
2015
77
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2017
257
0.030
 Why?
Posture
1
2015
196
0.030
 Why?
Cognition
1
2022
1258
0.030
 Why?
Genotype
1
2019
1833
0.030
 Why?
Leukocyte Common Antigens
1
2014
88
0.030
 Why?
Tropical Climate
1
2014
24
0.030
 Why?
Biota
1
2014
35
0.030
 Why?
Dinoprostone
1
2014
178
0.030
 Why?
Tumor Burden
1
2015
319
0.030
 Why?
Fresh Water
1
2014
56
0.030
 Why?
STAT5 Transcription Factor
1
2013
52
0.030
 Why?
Terminal Care
1
2018
279
0.030
 Why?
Trees
1
2014
67
0.030
 Why?
Blood Cell Count
1
2013
54
0.030
 Why?
Carbon Monoxide
1
2014
82
0.030
 Why?
Brazil
1
2014
179
0.030
 Why?
Dermoscopy
1
2013
11
0.020
 Why?
Clinical Decision-Making
1
2017
358
0.020
 Why?
Biomass
1
2014
116
0.020
 Why?
Immunoblotting
1
2014
300
0.020
 Why?
Rain
1
2014
49
0.020
 Why?
Massachusetts
1
2014
177
0.020
 Why?
Necrosis
1
2014
244
0.020
 Why?
Family Health
1
1994
191
0.020
 Why?
Oncogenes
1
2013
119
0.020
 Why?
Wnt Signaling Pathway
1
2015
210
0.020
 Why?
Photosynthesis
1
2014
98
0.020
 Why?
Lipopolysaccharide Receptors
1
2013
87
0.020
 Why?
beta Catenin
1
2015
252
0.020
 Why?
Child, Preschool
2
2021
11774
0.020
 Why?
Magnetic Resonance Imaging
1
2025
3857
0.020
 Why?
Fires
1
2014
87
0.020
 Why?
Karyotyping
1
2012
106
0.020
 Why?
Immune System
1
2014
179
0.020
 Why?
Opioid-Related Disorders
1
2021
576
0.020
 Why?
Gonadotropin-Releasing Hormone
1
2014
212
0.020
 Why?
Adiposity
1
2017
541
0.020
 Why?
Accidental Falls
1
2015
222
0.020
 Why?
Observer Variation
1
2013
354
0.020
 Why?
Endothelial Cells
1
2018
869
0.020
 Why?
Cell Division
1
2013
766
0.020
 Why?
Menopause
1
2015
319
0.020
 Why?
Carbon Dioxide
1
2014
242
0.020
 Why?
Comorbidity
1
2017
1646
0.020
 Why?
Calibration
1
2012
151
0.020
 Why?
Carcinogenesis
1
2013
229
0.020
 Why?
Recurrence
1
2015
1134
0.020
 Why?
Polymorphism, Single Nucleotide
1
2019
2143
0.020
 Why?
Interferon-gamma
2
2005
784
0.020
 Why?
RNA, Bacterial
1
2012
189
0.020
 Why?
Tomography, X-Ray Computed
2
2015
2730
0.020
 Why?
Seasons
1
2014
556
0.020
 Why?
Cell Differentiation
1
2018
2048
0.020
 Why?
Genome, Human
1
2013
422
0.020
 Why?
Mice, SCID
1
2011
369
0.020
 Why?
Cell Line
1
2016
2879
0.020
 Why?
Photochemotherapy
1
2010
39
0.020
 Why?
Self Report
1
2015
863
0.020
 Why?
Universities
1
2013
451
0.020
 Why?
Gene Expression Regulation, Bacterial
1
2012
327
0.020
 Why?
Feasibility Studies
1
2014
1087
0.020
 Why?
Hypertension
1
2018
1254
0.020
 Why?
Microscopy, Confocal
1
2010
321
0.020
 Why?
Matrix Metalloproteinases
1
2010
96
0.020
 Why?
Palliative Care
1
2018
996
0.020
 Why?
Survival Rate
1
2014
2088
0.020
 Why?
Keratin-19
1
2009
4
0.020
 Why?
Immunomagnetic Separation
1
2009
4
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
21
0.020
 Why?
Dose-Response Relationship, Immunologic
1
2009
76
0.020
 Why?
Diagnosis, Differential
1
2013
1487
0.020
 Why?
Physician-Patient Relations
1
2014
581
0.020
 Why?
Vinblastine
1
2009
75
0.020
 Why?
Blotting, Western
1
2011
1187
0.020
 Why?
Species Specificity
1
2010
574
0.020
 Why?
ADAM12 Protein
1
2008
4
0.020
 Why?
Flavonoids
1
2009
87
0.020
 Why?
Perilipin-1
1
2008
17
0.020
 Why?
Estrogen Receptor Modulators
1
2008
17
0.020
 Why?
S100 Proteins
1
2008
36
0.020
 Why?
Sex Factors
1
1994
2096
0.020
 Why?
ADAM Proteins
1
2008
63
0.020
 Why?
Androstadienes
1
2008
76
0.020
 Why?
Perimenopause
1
2008
66
0.020
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
132
0.020
 Why?
DNA Primers
1
2009
511
0.020
 Why?
Matrix Metalloproteinase 9
1
2008
131
0.020
 Why?
Radiotherapy
1
2008
206
0.020
 Why?
Prevalence
1
2014
2815
0.020
 Why?
Piperidines
1
2009
217
0.020
 Why?
Gene Expression
1
2012
1487
0.020
 Why?
Chi-Square Distribution
1
2008
527
0.020
 Why?
Precancerous Conditions
1
2008
166
0.020
 Why?
Cluster Analysis
1
2008
519
0.020
 Why?
Protein Structure, Tertiary
1
2009
862
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2008
758
0.010
 Why?
Pleural Effusion
1
2006
60
0.010
 Why?
Lymphocyte Culture Test, Mixed
1
2005
51
0.010
 Why?
Cytotoxicity Tests, Immunologic
1
2005
37
0.010
 Why?
Receptors, CCR7
1
2005
31
0.010
 Why?
Receptors, Chemokine
1
2005
47
0.010
 Why?
Antigens, CD34
1
2005
88
0.010
 Why?
Interleukin-12
1
2005
117
0.010
 Why?
Positron-Emission Tomography
1
2006
323
0.010
 Why?
Hemocyanins
1
2004
61
0.010
 Why?
Carrier Proteins
1
2008
736
0.010
 Why?
Coculture Techniques
1
2004
246
0.010
 Why?
Patient Care Planning
1
2005
169
0.010
 Why?
Cell Separation
1
2004
307
0.010
 Why?
Cell Nucleus
1
2006
618
0.010
 Why?
Tumor Cells, Cultured
1
2004
919
0.010
 Why?
Brain
1
2014
2930
0.010
 Why?
Paclitaxel
1
2003
255
0.010
 Why?
Pilot Projects
1
2003
1867
0.010
 Why?
Vaccination
1
2004
1422
0.010
 Why?
Borges's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (592) concept(s)
_
Co-Authors Expand Description
See all (69) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)